Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

  • Cord H. Sunderkötter*
  • , Bernhard Zelger
  • , Ko Ron Chen
  • , Luis Requena
  • , Warren Piette
  • , J. Andrew Carlson
  • , Jan Dutz
  • , Peter Lamprecht
  • , Alfred Mahr
  • , Elisabeth Aberer
  • , Victoria P. Werth
  • , David A. Wetter
  • , Seiji Kawana
  • , Raashid Luqmani
  • , Camille Frances
  • , Joseph Jorizzo
  • , J. Richard Watts
  • , Dieter Metze
  • , Marzia Caproni
  • , Erkan Alpsoy
  • Jeffrey P. Callen, David Fiorentino, Peter A. Merkel, Ronald J. Falk, J. Charles Jennette
*Korrespondierende/r Autor/-in für diese Arbeit
  • Martin-Luther Universität Halle-Wittenberg
  • University of Innsbruck
  • Universidad Autónoma de Madrid (CSIC-UAM)
  • Stroger Hospital of Cook County
  • Albany Medical College
  • University of British Columbia
  • Hôpital Saint-Louis
  • Medical University Graz
  • Mayo Clinic Rochester, MN
  • Nippon Medical School
  • Oxford University Hospitals NHS Foundation Trust
  • Pierre and Marie Curie University (UPMC, Paris 6)and Medical School
  • Wake Forest School of Medicine
  • University of East Anglia, Norwich Medical School
  • Westfälische Wilhelms-Universität Münster
  • University of Florence
  • Akdeniz University
  • University of Louisville
  • Stanford University
  • University of Pennsylvania
  • University of North Carolina

Abstract

Objective: To prepare a dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (CHCC2012) to address vasculitides affecting the skin (D-CHCC). The goal was to standardize the names and definitions for cutaneous vasculitis. Methods: A nominal group technique with a facilitator was used to reach consensus on the D-CHCC nomenclature, using multiple face-to-face meetings, e-mail discussions, and teleconferences. Results: Standardized names, definitions, and descriptions were adopted for cutaneous components of systemic vasculitides (e.g., cutaneous IgA vasculitis as a component of systemic IgA vasculitis), skin-limited variants of systemic vasculitides (e.g., skin-limited IgA vasculitis, drug-induced skin-limited antineutrophil cytoplasmic antibody–associated vasculitis), and cutaneous single-organ vasculitides that have no systemic counterparts (e.g., nodular vasculitis). Cutaneous vasculitides that were not included in the CHCC2012 nomenclature were introduced. Conclusion: Standardized names and definitions are a prerequisite for developing validated classification and diagnostic criteria for cutaneous vasculitis. Accurate identification of specifically defined variants of systemic and skin-limited vasculitides requires knowledgeable integration of data from clinical, laboratory, and pathologic studies. This proposed nomenclature of vasculitides affecting the skin, the D-CHCC, provides a standard framework both for clinicians and for investigators.

OriginalspracheEnglisch
ZeitschriftArthritis and Rheumatology
Jahrgang70
Ausgabenummer2
Seiten (von - bis)171-184
Seitenumfang14
ISSN2326-5191
DOIs
PublikationsstatusVeröffentlicht - 01.02.2018

Fördermittel

Supported in part by the European Academy of Dermatology and Venereology (grant 2014-028; Project on Nomenclature and Diagnostic Criteria of Cutaneous Vasculitis).

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren